Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Revenue (2016 - 2025)

Bioadaptives' Revenue history spans 7 years, with the latest figure at $10427.0 for Q4 2025.

  • On a quarterly basis, Revenue changed N/A to $10427.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $18278.0, a 44.27% increase, with the full-year FY2025 number at $18278.0, up 44.27% from a year prior.
  • Revenue hit $10427.0 in Q4 2025 for Bioadaptives, up from $4632.0 in the prior quarter.
  • Over the last five years, Revenue for BDPT hit a ceiling of $15649.0 in Q3 2023 and a floor of $675.0 in Q2 2024.
  • Historically, Revenue has averaged $5674.4 across 5 years, with a median of $4518.0 in 2021.
  • Biggest five-year swings in Revenue: plummeted 71.14% in 2024 and later surged 376.89% in 2025.
  • Tracing BDPT's Revenue over 5 years: stood at $3851.0 in 2021, then increased by 3.45% to $3984.0 in 2022, then skyrocketed by 80.75% to $7201.0 in 2023, then crashed by 90.63% to $675.0 in 2024, then surged by 1444.74% to $10427.0 in 2025.
  • Business Quant data shows Revenue for BDPT at $10427.0 in Q4 2025, $4632.0 in Q3 2025, and $3219.0 in Q2 2025.